AUGX - Augmedix, Inc. Stock Price, Fair Value and News

2.28USD+0.01 (+0.44%)Market Closed

Market Summary

USD2.28+0.01

Market Closed

0.44%

AUGX Stock Price

View Fullscreen

AUGX RSI Chart

AUGX Valuation

Market Cap

111.6M

Price/Earnings (Trailing)

-5.46

Price/Sales (Trailing)

2.29

EV/EBITDA

-4.26

Price/Free Cashflow

-5.33

AUGX Price/Sales (Trailing)

AUGX Profitability

Operating Margin

55.65%

EBT Margin

-41.89%

Return on Equity

-114.92%

Return on Assets

-34.31%

Free Cashflow Yield

-18.77%

AUGX Fundamentals

AUGX Revenue

Revenue (TTM)

48.7M

Rev. Growth (Yr)

39.91%

Rev. Growth (Qtr)

6.24%

AUGX Earnings

Earnings (TTM)

-20.4M

Earnings Growth (Yr)

-24.05%

Earnings Growth (Qtr)

-44.68%

Breaking Down AUGX Revenue

Last 7 days

0.9%

Last 30 days

168.2%

Last 90 days

-20%

Trailing 12 Months

-42.6%

How does AUGX drawdown profile look like?

AUGX Financial Health

Current Ratio

2.04

AUGX Investor Care

Shares Dilution (1Y)

20.39%

Diluted EPS (TTM)

-0.42

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	48.7M	0	0	0
2023	33.6M	37.0M	40.9M	44.9M
2022	24.4M	26.5M	28.8M	30.9M
2021	17.3M	18.8M	20.1M	22.2M
2020	14.7M	15.3M	15.9M	16.5M
2019	0	0	0	14.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Augmedix, Inc.

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Notes that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, a self-service mobile software application. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

CEO	Mr. Emmanuel Krakaris
WEBSITE	augmedix.com
INDUSTRY	Healthcare Plans
EMPLOYEES	1040

Augmedix, Inc. Frequently Asked Questions

What is the ticker symbol for Augmedix, Inc.? What does AUGX stand for in stocks?

AUGX is the stock ticker symbol of Augmedix, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Augmedix, Inc. (AUGX)?

As of Fri Jul 26 2024, market cap of Augmedix, Inc. is 111.65 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AUGX stock?

You can check AUGX's fair value in chart for subscribers.

Is Augmedix, Inc. a good stock to buy?

The fair value guage provides a quick view whether AUGX is over valued or under valued. Whether Augmedix, Inc. is cheap or expensive depends on the assumptions which impact Augmedix, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AUGX.

What is Augmedix, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, AUGX's PE ratio (Price to Earnings) is -5.46 and Price to Sales (PS) ratio is 2.29. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AUGX PE ratio will change depending on the future growth rate expectations of investors.